STAR BIO-TECH<1051> - Results Announcement
Star Bio-Tech (Holdings) Limited announced on 28/3/2001:
(stock code: 1051)
Please refer to the press announcement for the details of the auditors'
review report on the interim financial statement, issued by the Company on
29/3/2001.
Year end date: 30/6/2001
Currency: HK$ (Unaudited)
(Unaudited) Last
Current Corresponding (Unaudited)
Period Period 6-month ended
from 1/7/2000 from 1/7/1999 from 1/4/1999
to 31/12/2000 to 31/12/1999 to 30/9/1999
('000) ('000) ('000)
Turnover : 13,873 5,463 4,395
Profit/(Loss) from
Operations : (31,081) (10,745) (25,475)
Finance cost : (1,935) (4,989) N/A
Share of Profit/(Loss) of
Associates : NIL NIL (451)
Share of Profit/(Loss) of
Jointly Controlled
Entities : NIL NIL NIL
Profit/(Loss) after Tax
& MI : (31,416) (15,178) (25,926)
% Change over Last Period : N/A
EPS/(LPS)-Basic : (0.23 cent) (1.20 cents) (2.06 cents)
-Diluted : NIL NIL NIL
Extraordinary (ETD) Gain/
(Loss) : NIL NIL NIL
Profit/(Loss) after ETD
Items : (31,416) (15,178) (25,926)
Interim Dividend per Share: NIL NIL NIL
(Specify if with other
options) : - - -
B/C Dates for Interim
Dividend : N/A
Payable Date : N/A
B/C Dates for (-) General
Meeting : N/A
Other Distribution for
Current Period : N/A
B/C Dates for Other
Distribution : N/A
Remarks:
(1) An analysis of turnover and profit/(loss) from continuing operations
and discontinued operations
Continuing Discontinued
operations operations
HK$'000 HK$'000
Turnover 13,873 NIL
Profit/(Loss) (31,416) NIL
(2) Loss Per Share
The calculation of the basic loss per share is based on the net loss for
the period from 1st July, 2000 to 31st December, 2000 of HK$31,416,000
(1.7.1999 to 31.12.1999: loss of HK$15,178,000, 1.4.1999 to 30.9.1999:
loss of HK$25,926,000) and on the weighted average number of
13,449,180,892 (1.7.1999 to 31.12.1999: weighted average number of
1,261,264,520, 1.4.1999 to 30.9.1999: weighted average number of
1,261,264,520) shares in issue after adjustment for the share
consolidation on 14th June, 2000 to consolidate every two issued shares
into one share.
No diluted loss per share for the six months ended 31st December, 2000 has
been presented as the exercise of the share options would result in a
decrease in the loss per share for the current period.
No diluted loss per share for the six months ended 31st December, 1999 has
been presented as the exercise prices of the share options were greater
than the market prices of the Company's shares during the prior period.
(3) Please note that the Company has changed its financial year end date
from 31 March to 30 June. The current period's result covers six months to
December, 2001 whereas comparative figures covered results for six months
to December 1999 which was not audited nor announced before.
For more details, please refer to the press announcement today.
|
